PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 30 filers reported holding PROTARA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,380 | -30.1% | 20,587 | 0.0% | 0.00% | – |
| Q2 2023 | $49,203 | -23.6% | 20,587 | 0.0% | 0.00% | – |
| Q1 2023 | $64,437 | +20.1% | 20,587 | +2.8% | 0.00% | – |
| Q4 2022 | $53,651 | -9.1% | 20,019 | 0.0% | 0.00% | – |
| Q3 2022 | $59,000 | 0.0% | 20,019 | 0.0% | 0.00% | – |
| Q2 2022 | $59,000 | -42.2% | 20,019 | 0.0% | 0.00% | – |
| Q1 2022 | $102,000 | -32.0% | 20,019 | -9.9% | 0.00% | – |
| Q4 2021 | $150,000 | -2.6% | 22,215 | -0.3% | 0.00% | – |
| Q3 2021 | $154,000 | -29.0% | 22,279 | 0.0% | 0.00% | – |
| Q2 2021 | $217,000 | -75.7% | 22,279 | -60.7% | 0.00% | – |
| Q1 2021 | $892,000 | -41.7% | 56,676 | -10.3% | 0.00% | – |
| Q4 2020 | $1,530,000 | +146.4% | 63,212 | +71.3% | 0.00% | – |
| Q3 2020 | $621,000 | +28.0% | 36,894 | +123.3% | 0.00% | – |
| Q2 2020 | $485,000 | – | 16,523 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,558,472 | $43,059,000 | 8.42% |
| CVI Holdings, LLC | 168,836 | $2,842,000 | 1.16% |
| Soleus Capital Management, L.P. | 100,000 | $1,683,000 | 0.89% |
| Ikarian Capital, LLC | 722,443 | $12,158,000 | 0.88% |
| COWEN AND COMPANY, LLC | 124,171 | $2,090,000 | 0.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 782,670 | $13,172,000 | 0.32% |
| Cormorant Asset Management, LP | 450,000 | $7,574,000 | 0.29% |
| Rock Springs Capital Management LP | 643,622 | $10,832,000 | 0.28% |
| Perceptive Advisors | 608,544 | $10,242,000 | 0.15% |
| Maven Securities LTD | 100,000 | $1,688,000 | 0.14% |